Motoki Fujita

Dr. Motoki Fujita

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in Neurological Research
Verified
Journal Article
Closed access
YKYasutaka Koga
Yasutaka Koga
MFMotoki Fujita
Motoki Fujita
RTRyosuke Tsuruta
Ryosuke Tsuruta
YKYoichi Koda
Yoichi Koda
TNTakashi Nakahara
Takashi Nakahara
TMTsuyoshi Maekawa
Tsuyoshi Maekawa
Objectives: To investigate the effects of ulinastatin, a urinary trypsin inhibitor (UTI), on jugular venous superoxide radical (O−2·) generation, oxidative stress, early inflammation, and endothelial activation in forebrain ischemia/reperfusion (FBI/R) rats.Methods: Fourteen Wistar rats were allocated to a control group (n = 7) and a UTI group (n = 7). Throughout the experiments, O−2· in the jugular vein was measured by the produced current using a novel electrochemical O−2· sensor. Forebrain ischemia was induced by occlusion of the bilateral common caroti darteries with hemorrhagic hypotension for 20 min, followed by reperfusion. In the UTI group, UTI (5 U/g) was administered intravenously immediately after reperfusion. At 60 min after reperfusion, plasma and brain were harvested, and malondialdehyde, high-mobility group box 1 (HMGB1) protein, and intercellular adhesion molecule-1 (ICAM-1) were measured. Results: O−2· current increased gradually during forebrain ischemia in both groups. The current increased markedly in the control group immediately after reperfusion but was significantly attenuated in the UTI group after reperfusion. Brain and plasma malondialdehyde, HMGB1, and ICAM-1 were significantly attenuated in the UTI group compared with those in the control group, except for brain HMGB1, which was associated with the amount of O−2· generated during FBI/R. Discussion: UTI suppressed jugular venous O−2· generation, oxidative stress, early inflammation, and endothelial activation in FBI/R rats. Therefore, UTI might be a useful agent for the therapy of the cerebral ischemia/reperfusion pathophysiology.

TYTakahiro Yamamoto
Takahiro Yamamoto
MFMotoki Fujita
Motoki Fujita
YOYaustaka Oda
Yaustaka Oda
MTMasaki Todani
Masaki Todani
THToru Hifumi
Toru Hifumi
RTRyosuke Tsuruta
Ryosuke Tsuruta
The Japanese Association for Acute Medicine Committee recently proposed a novel classification system for the severity of heat-related illnesses. The illnesses are simply classified into three stages based on symptoms and management or treatment. Stages I, II, and III broadly correspond to heat cramp and syncope, heat exhaustion, and heat stroke, respectively. Our objective was to examine whether this novel severity classification is useful in the diagnosis by healthcare professionals of patients with severe heat-related illness and organ failure. A nationwide surveillance study of heat-related illnesses was conducted between 1 June and 30 September 2012, at emergency departments in Japan. Among the 2130 patients who attended 102 emergency departments, the severity of their heat-related illness was recorded for 1799 patients, who were included in this study. In the patients with heat cramp and syncope or heat exhaustion (but not heat stroke), the blood test data (alanine aminotransferase, creatinine, blood urea nitrogen, and platelet counts) for those classified as Stage III were significantly higher than those of patients classified as Stage I or II. There were no deaths among the patients classified as Stage I. This novel classification may avoid underestimating the severity of heat-related illness.

31 August 2015 in Resuscitation
Verified
Journal Article
Closed access
PDF file
YKYasutaka Koga
Yasutaka Koga
MFMotoki Fujita
Motoki Fujita
TYTakeshi Yagi
Takeshi Yagi
TNTakashi Nakahara
Takashi Nakahara
TMTakashi Miyauchi
Takashi Miyauchi
RTRyosuke Tsuruta
Ryosuke Tsuruta

29 April 2016 in Journal of Intensive Care
Verified
Journal Article
Open access
PDF file
SFShinya Fukuda
Shinya Fukuda
TMTakashi Miyauchi
Takashi Miyauchi
MFMotoki Fujita
Motoki Fujita
YOYasutaka Oda
Yasutaka Oda
MTMasaki Todani
Masaki Todani
RTRyosuke Tsuruta
Ryosuke Tsuruta
Late defecation was recently reported to be associated with worse clinical outcomes in critically ill patients. However, more research is needed to examine the causes and clinical significance of late defecation. The objectives of this study were to investigate the risk factors for late defecation and its association with the outcomes of intensive care unit (ICU) patients. Patients in an ICU for ≥7 days between January and December 2011 were retrospectively assessed. Based on the time between admission and the first defecation, they were assigned to early (<6 days; n = 186) or late (≥6 days; n = 96) defecation groups. Changes in clinical variables between admission and ICU day 7 were assessed to investigate the effects of late defecation. The clinical outcomes were ICU mortality, length of ICU stay, and length of mechanical ventilation. Late enteral nutrition (odds ratio (OR) 3.42; 95 % confidence interval (CI) 1.88–6.22; P < 0.001), sedatives (OR 3.07; 95 % CI 1.71–5.52; P < 0.001), and surgery (OR 1.86; 95 % CI 1.01–3.42; P = 0.047) were the independent risk factors for late defecation. The median (interquartile) changes in body temperature (0.3 [−0.4 to 1.0] vs 0.7 [0.1 to 1.5] °C; P = 0.004), serum C-reactive protein concentration (1.6 [−0.5 to 6.6] vs 3.5 [0.7 to 8.5] mg/dL; P = 0.035), and Sequential Organ Failure Assessment score (−1 [−2 to 1] vs 0 [−1 to 2]; P = 0.008) between admission and ICU day 7 were significantly greater in the late defecation group than in the early defecation group. ICU stay was significantly longer in the late defecation group (12 [9 to 19] vs 16 [10 to 23] days; P = 0.021), whereas ICU mortality and the length of mechanical ventilation were similar in both groups. Late enteral nutrition, sedatives, and surgery were independent the risk factors for late defecation in critically ill patients. Late defecation was associated with prolonged ICU stay.

18 June 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MFMotoki Fujita
Motoki Fujita
MTMasaki Todani
Masaki Todani
KKKotaro Kaneda
Kotaro Kaneda
SSShinya Suzuki
Shinya Suzuki
SWShinjiro Wakai
Shinjiro Wakai
OIon behalf of the COP-J Study Investigators
on behalf of the COP-J Study Investigators
Background: The purpose of this study was to clarify the practical clinical treatment for acute carbon monoxide (CO) poisoning in Japan and to investigate the efficacy of hyperbaric oxygen (HBO2) therapy in preventing delayed neurological sequelae (DNS) in the acute phase of CO poisoning. Methods: We conducted a multicenter, prospective, observational study of acute CO poisoning in Japan. Patients with acute CO poisoning were enrolled and their treatment details were recorded. The primary endpoint was the onset of DNS within 2 months of CO exposure. Factors associated with DNS were assessed with logistic regression analysis. Results: A total of 311 patients from 57 institutions were registered and 255 were analyzed: 171 received HBO2 therapy (HBO2 group) and 84 did not (normobaric oxygen [NBO2] group). HBO2 therapy was performed zero, once, twice, or three times within the first 24 h in 1.8%, 55.9%, 30.9%, and 11.3% of the HBO2 group, respectively. The treatment pressure in the first HBO2 session was 2.8 ATA (47.9% of the HBO2 group), 2.0 ATA (41.8%), 2.5 ATA (7.9%), or another pressure (2.4%). The incidence of DNS was 13/171 (7.6%) in the HBO2 group and 3/84 (3.6%) in the NBO2 group (P = 0.212). The number of HBO2 sessions in the first 24 h was one of the factors associated with the incidence of DNS (odds ratio, 2.082; 95% confidence interval, 1.101–3.937; P = 0.024). Conclusions: The practical clinical treatment for acute CO poisoning, including HBO2 therapy, varied among the institutions participating in Japan. HBO2 therapy with inconsistent protocols showed no advantage over NBO2 therapy in preventing DNS. Multiple HBO2 sessions was associated with the incidence of DNS.

1 October 2009 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
MFMotoki Fujita
Motoki Fujita
RTRyosuke Tsuruta
Ryosuke Tsuruta
SKShunji Kasaoka
Shunji Kasaoka
KFKenji Fujimoto
Kenji Fujimoto
RTRyo Tanaka
Ryo Tanaka
TMTsuyoshi Maekawa
Tsuyoshi Maekawa